|New molecular insights into osteosarcoma targeted therapy|
J Yang, W Zhang
Current opinion in oncology 25 (4), 398-406, 2013
|Advances in targeted therapy for osteosarcoma|
W Zhou, M Hao, X Du, K Chen, G Wang, J Yang
Discovery medicine 17 (96), 301-307, 2014
|Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma|
J Yang, D Yang, Y Sun, B Sun, G Wang, JC Trent, DM Araujo, K Chen, ...
Cancer 117 (21), 4925-4938, 2011
|Histone deacetylase 6 in cancer|
T Li, C Zhang, S Hassan, X Liu, F Song, K Chen, W Zhang, J Yang
Journal of hematology & oncology 11 (1), 1-10, 2018
|Genetic aberrations of gastrointestinal stromal tumors|
J Yang, X Du, AJF Lazar, R Pollock, K Hunt, K Chen, X Hao, J Trent, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
|Genetic aberrations in soft tissue leiomyosarcoma|
J Yang, X Du, K Chen, A Ylipää, AJF Lazar, J Trent, D Lev, R Pollock, ...
Cancer letters 275 (1), 1-8, 2009
|Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug|
J Yang, JA Eddy, Y Pan, A Hategan, I Tabus, Y Wang, D Cogdell, ...
Molecular & Cellular Proteomics 9 (11), 2405-2413, 2010
|Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma|
J Yang, D Cogdell, D Yang, L Hu, H Li, H Zheng, X Du, Y Pang, J Trent, ...
Cancer letters 291 (1), 31-38, 2010
|Mesenchymal to epithelial transition in sarcomas|
J Yang, X Du, G Wang, Y Sun, K Chen, X Zhu, AJF Lazar, KK Hunt, ...
European journal of cancer 50 (3), 593-601, 2014
|Genomic and molecular characterization of malignant peripheral nerve sheath tumor identifies the IGF1R pathway as a primary target for treatment|
J Yang, A Ylipää, Y Sun, H Zheng, K Chen, M Nykter, J Trent, N Ratner, ...
Clinical cancer research 17 (24), 7563-7573, 2011
|Efficacy and safety of Apatinib in stage IV sarcomas: experience of a major sarcoma center in China|
F Li, Z Liao, J Zhao, G Zhao, X Li, X Du, Y Yang, J Yang
Oncotarget 8 (38), 64471, 2017
|Advances in targeted therapy for unresectable melanoma: new drugs and combinations|
M Hao, F Song, X Du, G Wang, Y Yang, K Chen, J Yang
Cancer letters 359 (1), 1-8, 2015
|Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors|
A Ylipää, KK Hunt, J Yang, AJF Lazar, KE Torres, DC Lev, M Nykter, ...
Cancer 117 (2), 380-389, 2011
|APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma: Correlation with Recurrence, Metastasis, and Survival|
J Yang, D Yang, D Cogdell, X Du, H Li, Y Pang, Y Sun, L Hu, B Sun, ...
Technology in cancer research & treatment 9 (2), 161-169, 2010
|The genetic basis for inactivation of Wnt pathway in human osteosarcoma|
X Du, J Yang, D Yang, W Tian, Z Zhu
BMC cancer 14 (1), 1-10, 2014
|Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis|
Y Jilong, W Jian, Z Xiaoyan, L Xiaoqiu, Z Xiongzeng
Pathology 39 (3), 319-325, 2007
|Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma|
Z Ren, S Liang, J Yang, X Han, L Shan, B Wang, T Mu, Y Zhang, X Yang, ...
Tumor Biology 37 (4), 5089-5096, 2016
|WWOX tumor suppressor gene|
J Yang, W Zhang
Histology and histopathology, 2008
|Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor|
Q Fan, J Yang, G Wang
Clinical and Translational Oncology 16 (2), 191-199, 2014
|Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy|
J Yang, X Du
Surgical oncology 22 (3), e53-e57, 2013